Abstract
Letter| March 16, 2023 A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in newly-diagnosed iMCD patients Hao Zhao, Hao Zhao Peking Union Medical College Hospital, Beijing, China https://orcid.org/0000-0003-0736-9700 Search for other works by this author on: This Site PubMed Google Scholar Miao-yan Zhang, Miao-yan Zhang Peking Union Medical College Hospital, Beijing, China Search for other works by this author on: This Site PubMed Google Scholar Kai-ni Shen, Kai-ni Shen Peking Union Medical College Hospital, Beijing, China Search for other works by this author on: This Site PubMed Google Scholar Jun Feng, Jun Feng Peking Union Medical College Hospital, Beijing, Florida, China Search for other works by this author on: This Site PubMed Google Scholar Xin-xin Cao, Xin-xin Cao Peking Union Medical College Hospital, Beijing, China Search for other works by this author on: This Site PubMed Google Scholar Ming-hui Duan, Ming-hui Duan Peking Union Medical College Hospital, Beijing, China https://orcid.org/0000-0003-2130-6300 Search for other works by this author on: This Site PubMed Google Scholar Dao-bin Zhou, Dao-bin Zhou Peking Union Medical College Hospital, Chinese Academy Medical Society&Peking Union Medical College, Beijing, China Search for other works by this author on: This Site PubMed Google Scholar Lu Zhang, Lu Zhang Peking Union Medical College Hospital, Beijing, China * Corresponding Author; email: pumczhanglu@163.com Search for other works by this author on: This Site PubMed Google Scholar Jian Li, Prof Jian Li, Prof Peking Union Medical College Hospital, Chinese Academy Medical Society&Peking Union Medical College, Beijing, China https://orcid.org/0000-0002-4549-0694 Search for other works by this author on: This Site PubMed Google Scholar Blood blood.2023020009. https://doi.org/10.1182/blood.2023020009 Article history Submitted: February 6, 2023 Revision Received: March 9, 2023 Accepted: March 11, 2023 Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Request Permissions Cite Icon Cite Search Site Citation Hao Zhao, Miao-yan Zhang, Kai-ni Shen, Jun Feng, Xin-xin Cao, Ming-hui Duan, Dao-bin Zhou, Lu Zhang, Jian Li; A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in newly-diagnosed iMCD patients. Blood 2023; blood.2023020009. doi: https://doi.org/10.1182/blood.2023020009 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBlood Search Subjects: Lymphoid Neoplasia This content is only available as a PDF. Copyright © 2023 American Society of Hematology2023 Article PDF first page preview Close Modal You do not currently have access to this content. Sign in via your Institution
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
